Dermatology Service, Veterans Affairs Medical Center, San Francisco, California.
Department of Dermatology, University of California, San Francisco.
JAMA Dermatol. 2015 May;151(5):513-21. doi: 10.1001/jamadermatol.2014.5634.
Effective patient-physician communication is essential for optimal health care. Recent introduction of online patient portals to access test results are changing the communication landscape, but regulatory guidelines for the online release of biopsy results vary from state to state.
To assess patient preferences for receiving skin biopsy results to rule out melanoma and to compare those preferences to current physicians' practices for notification.
DESIGN, SETTING, AND PARTICIPANTS: English-speaking individuals 18 years or older were recruited consecutively from melanoma clinics at 3 academic tertiary referral medical centers: University of California, San Francisco, University of Pennsylvania, and Duke University. Patients were surveyed from July 1, 2012, through July 31, 2013. A second survey of physicians at these institutions was conducted to assess physician notification practices.
A total of 301 of 305 patients agreed to participate (98.7 response rate). Most of the patients (67.1%) preferred to speak directly with their physician by telephone to receive their skin biopsy results, followed by a distant second choice (19.5%) of being notified in person at a clinic visit. Voice message or online patient portal were each the preferred method of communication for 5.1% of patients. The most important consideration for patients was a communication modality that provided test results in the most rapid manner; 51.7% wanted a method that was rapid, and 7.8% preferred a method that was not only speedy but also allowed them an opportunity to ask questions. A total of 59.5% of the study participants would choose the same communication method regardless of the biopsy results, but 40.5% preferred a different mode of notification if their biopsy results revealed a malignant tumor. Younger and more highly educated patients favored the online portal. Of 84 physicians surveyed, 47 responded (56% response rate). Physicians' overall preferred method of contacting patients aligned with patient preference for speaking by telephone (56.5%). However, for benign results, 31.2% of physicians chose to speak by telephone, whereas patients preferred voicemail (32.1%). There was physician uncertainty as to guidelines regarding communication of test results.
Patient preference has shifted from face-to-face visit to discussion over the telephone because of a desire for rapid notification. Experience with online portal delivery of results favorably inclined patients toward that modality. We recommend that patients be queried regarding their notification preference on the biopsy consent form.
有效的医患沟通对于获得最佳的医疗保健至关重要。最近,在线患者门户的引入改变了医患沟通的方式,以便获取检测结果,但各州关于活检结果在线发布的监管指南却有所不同。
评估患者对于接收皮肤活检结果以排除黑色素瘤的偏好,并将这些偏好与目前医生的通知实践进行比较。
设计、设置和参与者:连续从加州大学旧金山分校、宾夕法尼亚大学和杜克大学 3 所学术性三级转诊医疗中心的黑色素瘤诊所招募了 301 名 18 岁或以上的讲英语的个体。于 2012 年 7 月 1 日至 2013 年 7 月 31 日进行患者调查。对这些机构的医生进行了第二次调查,以评估医生的通知实践。
共有 305 名患者中的 301 名同意参与(98.7%的回应率)。大多数患者(67.1%)更喜欢通过电话直接与医生通话来获取皮肤活检结果,其次是第二位选择(19.5%),即在诊所就诊时亲自通知。5.1%的患者更喜欢语音留言或在线患者门户作为沟通方式。对于患者来说,最重要的考虑因素是提供检测结果的最快捷的沟通方式;51.7%的患者希望采用快速的方法,7.8%的患者希望采用既快速又能让他们有机会提问的方法。共有 59.5%的研究参与者无论活检结果如何,都会选择相同的沟通方式,但如果活检结果显示为恶性肿瘤,40.5%的人则更喜欢不同的通知方式。年轻和受教育程度较高的患者更喜欢在线门户。在接受调查的 84 名医生中,有 47 名(56%的回应率)做出了回应。医生联系患者的首选方法与患者希望通过电话交谈的偏好一致(56.5%)。然而,对于良性结果,31.2%的医生选择通过电话通知,而患者则更喜欢语音邮件(32.1%)。对于测试结果的沟通指南,医生们存在不确定性。
由于希望快速通知,患者的偏好已经从面对面就诊转变为电话讨论。在线门户提供结果的经验使患者对该模式产生了好感。我们建议在活检同意书上询问患者关于通知偏好的问题。